TAVI frente a cirugía convencional aórtica. ¿Dónde están los límites?

Abstract

Transcatheter aortic valve implantation (TAVI) has experienced an increase in the number of procedures of 50% with its expansion to low risk, over the numbers obtained with high and intermediate risks. Recently, updates have been made public in the follow-up of the main randomized clinical studies (RCTs) in this group of patients. Although the results of these studies have served as a basis for recommending TAVI in elderly patients with intermediate or high risks, there are still several aspects that need to be clarified before expanding, in an indiscriminate or unselected manner to low-risk young patients. This review's aim is to analyze the results available in the published evidence, as well as the most significant variables that can affect their consistency, both in early and long term; for consideration in individualized patient-centered decision making.